Last Updated: May 14, 2026

QUINAPRIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Quinapril patents expire, and when can generic versions of Quinapril launch?

Quinapril is a drug marketed by Actavis Elizabeth, Actavis Labs Fl Inc, Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Lupin, Mylan, Pharmobedient, Prinston Inc, Sun Pharm Inds Ltd, Apotex, and Aurobindo Pharma. and is included in nineteen NDAs.

The generic ingredient in QUINAPRIL is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for QUINAPRIL?
  • What are the global sales for QUINAPRIL?
  • What is Average Wholesale Price for QUINAPRIL?
Summary for QUINAPRIL
US Patents:0
Applicants:14
NDAs:19
Drug Prices: Drug price information for QUINAPRIL
DailyMed Link:QUINAPRIL at DailyMed
Drug patent expirations by year for QUINAPRIL
Drug Prices for QUINAPRIL

See drug prices for QUINAPRIL

Drug Sales Revenue Trends for QUINAPRIL

See drug sales revenues for QUINAPRIL

US Patents and Regulatory Information for QUINAPRIL

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 205823-001 Sep 15, 2016 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lupin QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 077690-004 Jun 20, 2006 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds Ltd QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 076607-003 Dec 15, 2004 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 076374-002 Mar 31, 2004 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds Ltd QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 076607-001 Dec 15, 2004 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds Ltd QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 090800-003 Jun 18, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Apotex QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 091524-003 Mar 12, 2013 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links